Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Abcam board of directors update

    Abcam plc (LSE:ABC), Cambridge, U.K. Business: Antibodies Departing: Mike Redmond as chairman, effective this year; he will be succeeded by Murray Hennessy, a director

    Published on 7/14/2014
  • Actavis board of directors update

    Actavis plc (NYSE:ACT), Dublin, Ireland Business: Generics, Genitourinary Appointed: Nesli Basgoz, formerly a director at Forest Laboratories Inc., which Actavis acquired; Paul Bisaro as executive chairman, a newly …

    Published on 7/14/2014
  • Actavis management update

    Actavis plc (NYSE:ACT), Dublin, Ireland Business: Generics, Genitourinary Hired: Bill Meury as EVP of commercial, North American brands, formerly EVP of sales and marketing at Forest Laboratories Inc., which Actavis …

    Published on 7/14/2014
  • Alere Inc management update

    Alere Inc. (NYSE:ALR), Waltham, Mass. Business: Diagnostic Resigned: Jerry McAleer as SVP of R&D and a director; Dave Scott as CSO; and Ron Zwanziger as president, CEO and a director Transitioned: Namal Nawana to …

    Published on 7/14/2014
  • Alexza Pharmaceuticals Inc management update

    Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif. Business: Drug delivery, Neurology Promoted: Edwin Kamemoto to SVP of regulatory affairs, a newly created position, from VP of regulatory affairs

    Published on 7/14/2014
  • ALK-Abello management update

    ALK-Abello A/S (CSE:ALK-B), Horsholm, Denmark Business: Inflammation Hired: Helle Skov as EVP of product supply, formerly VP and head of global supply chain at Takeda Pharmaceutical Co. Ltd.

    Published on 7/14/2014
  • Applied Genetic Technologies Corp management update

    Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Business: Gene/Cell therapy Hired: Matthew Feinsod, founder and formerly CMO of Imagen Biotech Inc., as product development officer

    Published on 7/14/2014
  • Arch Therapeutics Inc management update

    Arch Therapeutics Inc. (OTCQB:ARTH), Wellesley, Mass. Business: Hematology Hired: Richard Davis as CFO and treasurer, formerly president, COO and CFO of NMT Medical Inc.; he replaces Alan Barber, who resigned

    Published on 7/14/2014
  • Avalanche Biotechnologies Inc management update

    Avalanche Biotechnologies Inc., Menlo Park, Calif. Business: Ophthalmic Hired: Samuel Barone as CMO, formerly a medical officer in FDAs Office of Cellular, Tissue and Gene Therapies

    Published on 7/14/2014
  • Baxter International Inc management update

    Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Pharmaceuticals Hired: James Saccaro as CFO, effective Aug. 4, formerly SVP and CFO of Hill-Rom Corp.; he will succeed Robert Hombach, who will be CFO of …

    Published on 7/14/2014
  • Bayer management update

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Pharmaceuticals Hired: Brian McCullough as director of operations for U.S. government relations, formerly a senior professional staffer of the U.S. House of …

    Published on 7/14/2014
  • Bellerophon Therapeutics LL management update

    Bellerophon Therapeutics LLC, Hampton, N.J. Business: Cardiovascular Hired: Jonathan Peacock as CEO and chairman, formerly EVP and CFO of Amgen Inc; he succeeds interim CEO and Chairman Daniel Tasse, who remains a …

    Published on 7/14/2014
  • Boston Therapeutics Inc management update

    Boston Therapeutics Inc. (OTCQB:BTHE), Manchester, N.H. Business: Endocrine/Metabolic, Inflammation, Chemistry Hired: Benjamin Rivnay as chief scientist, a newly created position, formerly director of R&D at Formatech …

    Published on 7/14/2014
  • Capnia Inc management update

    Capnia Inc., Palo Alto, Calif. Business: Neurology, Inflammation Hired: David OToole as CFO, formerly CFO of Codexis Inc.

    Published on 7/14/2014
  • Cibus Global Ltd management update

    Cibus Global Ltd., San Diego, Calif. Business: Gene/Cell therapy Promoted: Greg Gogal to SVP of R&D from VP of research Retired: Keith Walker as president and CEO, while becoming a director; he is succeeded by Peter …

    Published on 7/14/2014
  • Deciphera Pharmaceuticals LL management update

    Deciphera Pharmaceuticals LLC, Lawrence, Kan. Business: Cancer Hired: Oliver Rosen as CMO, formerly VP of global and medical affairs at Millennium Pharmaceuticals Inc., a subsidiary of Takeda Pharmaceutical Co. Ltd.

    Published on 7/14/2014
  • Jounce Therapeutics Inc management update

    Jounce Therapeutics Inc., Cambridge, Mass. Business: Cancer Hired: Richard Murray as CEO, formerly SVP of biologics and vaccines research at Merck & Co. Inc.; he succeeds interim CEO Cary Pfeffer, who becomes chairman

    Published on 7/14/2014
  • Kolltan Pharmaceuticals Inc management update

    Kolltan Pharmaceuticals Inc., New Haven, Conn. Business: Cancer, Antibodies Promoted: Jane Henderson to CFO, while remaining SVP and CBO

    Published on 7/14/2014
  • Midatech Ltd management update

    Midatech Ltd., Abingdon, U.K. Business: Drug delivery Hired: Nick Robbins-Cherry as finance director

    Published on 7/14/2014
  • Nanomix Inc management update

    Nanomix Inc., Emeryville, Calif. Business: Diagnostic Hired: Brian Jung as VP of finance and CFO, formerly chief business development officer of Alameda Hospital

    Published on 7/14/2014
  • NightstaRx Inc. management update

    NightstaRx Inc., London, U.K. Business: Gene/Cell therapy, Ophthalmic Hired: Aniz Girach as CMO, formerly global head of ophthalmology at ThromboGenics N.V.

    Published on 7/14/2014
  • NuVasive Inc management update

    NuVasive Inc. (NASDAQ:NUVA), San Diego, Calif. Business: Musculoskeletal Hired: Carol Cox as EVP of strategy and corporate communications, a newly created position, and as a member of the companys executive committee, …

    Published on 7/14/2014
  • Onkaido Therapeutics management update

    Onkaido Therapeutics LLC, Cambridge, Mass. Business: Cancer, Endocrine/Metabolic, Hematology Hired: Stephen Kelsey as president, effective July 21, formerly SVP of new projects at Medivation Inc.

    Published on 7/14/2014
  • Oxford Immunotec Global management update

    Oxford Immunotec Global plc (NASDAQ:OXFD), Abingdon, U.K. Business: Diagnostic Hired: Louis ODea as CMO, formerly head of regulatory affairs and CMO of Moderna Therapeutics Inc.

    Published on 7/14/2014
  • Paratek Pharmaceuticals Inc management update

    Paratek Pharmaceuticals Inc., Boston, Mass. Business: Infectious Hired: Michael Bigham, a partner at Paratek investor Abingworth, as CEO and chairman; he succeeds CEO Dennis Molnar, who remains a member of the senior …

    Published on 7/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993